| No (N=57) |
Yes (N=12) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 56.3 (9.39) | 57.3 (13.5) | 0.279 |
| Median [Min, Max] | 57.0 [33.0, 82.0] | 58.0 [24.0, 79.0] | |
| Operation_history | |||
| Direct_surgery | 42 (73.7%) | 3 (25.0%) | 0.00392 |
| Surgery_after_neoadjuvant | 15 (26.3%) | 9 (75.0%) | |
| Type | |||
| HGSC | 57 (100%) | 12 (100%) | <0.001 |
| Clinical_stage | |||
| II | 3 (5.3%) | 0 (0%) | 0.0655 |
| III | 32 (56.1%) | 3 (25.0%) | |
| IV | 22 (38.6%) | 9 (75.0%) | |
| TMB_group | |||
| High | 1 (1.8%) | 1 (8.3%) | 0.782 |
| Low | 55 (96.5%) | 11 (91.7%) | |
| Missing | 1 (1.8%) | 0 (0%) | |
| Planting_metastasis | |||
| No | 3 (5.3%) | 1 (8.3%) | 1 |
| Yes | 54 (94.7%) | 11 (91.7%) | |
| Lymph.node_metastasis | |||
| No | 23 (40.4%) | 4 (33.3%) | 0.899 |
| Yes | 34 (59.6%) | 8 (66.7%) | |
| Type_group | |||
| HGSC | 57 (100%) | 12 (100%) | <0.001 |